Literature DB >> 2886992

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

S M Wahl, D A Hunt, L M Wakefield, N McCartney-Francis, L M Wahl, A B Roberts, M B Sporn.   

Abstract

Recent studies have focused on the potential role of transforming growth factor type beta (TGF-beta) as an immunoregulatory peptide. In this context, we demonstrate that TGF-beta is a potent chemoattractant for human peripheral blood monocytes. At concentrations from 0.1 to 10 pg/ml, TGF-beta induces directed monocyte migration in vitro. Consistent with this observation is the expression of high-affinity TGF-beta receptors on the monocytes with a Kd of 1-10 pM. At higher concentrations of TGF-beta (greater than or equal to 1 ng/ml), monocytes are stimulated to generate biologically active mediator(s) that enhance fibroblast growth. Gene expression for one of these growth factors, interleukin 1, is induced in monocytes within hours after exposure to TGF-beta. Thus, TGF-beta may provide an important signal for monocyte recruitment and for regulation of their synthesis of mediators of fibroblast growth and activity in wound healing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886992      PMCID: PMC298948          DOI: 10.1073/pnas.84.16.5788

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Co-expression of chemotactic ligand receptors on human peripheral blood monocytes.

Authors:  K Ohura; I M Katona; L M Wahl; D E Chenoweth; S M Wahl
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

2.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production.

Authors:  S M Wahl; L M Wahl; J B McCarthy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

3.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

4.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.

Authors:  T F Deuel; R M Senior; J S Huang; G L Griffin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo.

Authors:  M B Sporn; A B Roberts; J H Shull; J M Smith; J M Ward; J Sodek
Journal:  Science       Date:  1983-03-18       Impact factor: 47.728

7.  Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders.

Authors:  P B Bitterman; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

9.  Transforming growth factors from neoplastic and nonneoplastic tissues.

Authors:  A B Roberts; C A Frolik; M A Anzano; M B Sporn
Journal:  Fed Proc       Date:  1983-06

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  285 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.

Authors:  SangKon Oh; J Michael McCaffery; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  bFGF and TGFbeta expression in rat kidneys after ischemic/ reperfusional gut injury and its relationship with tissue repair.

Authors:  Yin-Hui Yang; Xiao-Bing Fu; Tong-Zhu Sun; Li-Xian Jiang; Xiao-Man Gu
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

4.  The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

Authors:  A Panoskaltsis-Mortari; P A Taylor; T M Yaeger; O D Wangensteen; P B Bitterman; D H Ingbar; D A Vallera; B R Blazar
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.

Authors:  R E Wager; R K Assoian
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

6.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 7.  Protein factors which regulate cell motility.

Authors:  E M Rosen; I D Goldberg
Journal:  In Vitro Cell Dev Biol       Date:  1989-12

8.  Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts.

Authors:  Ho-Soon Choi; Christopher E Savard; Jae-Woon Choi; Rahul Kuver; Sum P Lee
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

Review 9.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

10.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.